As of the second quarter of 2025, 11 million unique patients were using a GLP-1 across indications, having consistently grown year-over-year
Although swelling of the abdominal aorta, which is a characteristic feature of inflammation, was observed in the Con-DSS group on the 5th day after DSS administration, there were no significant changes in the aorta before and after DSS administration in the Si-DSS group (Fig
GLP-1 Receptor Agonist Shortage: Australian perspective Limited Ozempic (semaglutide) stock is starting to return to pharmacies Although there will be small quantities of semaglutide available at local pharmacies during the second quarter of 2023 (according to distributors), supply will remain quite limited for some time
N Engl J Med 2021;384:989-1002)
Sometimes it delivers nothing at all
If you are already established on a GLP-1 medication, please select the tier that aligns with your current weekly dose